Clin2
NCT06362447Possibly a fitNot yet recruiting

Gentamicin injections for inherited ichthyosis

Ichthyosis

Treatments studied

Part of Genetic & congenital, Skin clinical trials.

This trial tests if gentamicin injections can improve symptoms of hereditary ichthyosis, a genetic skin condition. It is for adults with moderate to severe forms caused by specific gene mutations.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
26 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be 18–75 years old
  • You must have a specific genetic mutation (non-sense mutation) in one of these genes: TGM1, PNPLA1, ALOX12B, NIPAL4, ALOXE3, SDR9C7, ABCA12, CERS3, SPINK5, or CDSN
  • You must have moderate to severe ichthyosis, with at least two body areas affected (back, arms, legs, or feet)
  • You must not have used gentamicin or similar antibiotics in the last 3 months
  • You must not have kidney problems or hearing loss not caused by earwax

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03417856Enrolling by invitation
Study skin and blood signs in ichthyosis

This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.

Chicago, Illinois
NCT06136403Recruiting· Phase 2
Deucravacitinib for genetic skin disorders

This study tests a medication called deucravacitinib for adults with rare genetic skin conditions that cause blisters or severe scaling. The goal is to see if it can reduce symptoms safely.

Nice, CHU de NICE
NCT07783165Not yet recruiting
Moisturizer study for ichthyosis

This study tests a new moisturizer called Doublebase Once, applied once daily, to see if it is safe and works well for people with ichthyosis. Participants will use the study moisturizer for one month instead of their usual one.

NCT03526159Recruiting· Phase 1/Phase 2
Gentamicin treatment for certain skin blistering disease

This trial tests gentamicin, an antibiotic, for junctional epidermolysis bullosa (JEB) caused by a specific kind of genetic change in the LAMB3 gene. It may help some people with this exact mutation, but you must meet several safety and genetic requirements to join.

Los Angeles, California
NCT07689435Not yet recruiting
Cholesterol cream vs urea cream for ichthyosis skin health

This trial compares two creams to see which one improves skin barrier function and quality of life better for ichthyosis patients. You would apply either the cholesterol cream or the urea cream daily for a period to find out if one works better than the other.

Bangkok, Bangkok
NCT06545695Not yet recruiting· Phase 1/Phase 2
Testing an EGFR inhibitor for skin conditions called keratinopathies

This trial tests an oral drug called erlotinib (an EGFR inhibitor) in adults with certain genetic skin disorders. It aims to reduce symptoms of thickened, blistering or scaly skin. You may be able to join if you have a confirmed genetic form of these conditions and your skin is moderately affected.

Chicago, Illinois

Hear when a new Ichthyosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.